.
ࡱ > ;
&
'
(
)
*
+
,
-
.
/
0
1
2
3
4
5
6
7
8
9
:
\ p WorkStation B a = -B0=830 = XY.8 `@ " 1 " A r i a l C y r 1 " A r i a l C y r 1 " A r i a l C y r 1 " A r i a l C y r 1 " A r i a l C y r 1 " @ A r i a l C y r 1 " A r i a l C y r 1 6 T i m e s N e w R o m a n C y r 1 T a h o m a 1 " A r i a l C y r 1 " A r i a l C y r 1 " h A r i a l C y r 1 A r i a l 1 " A r i a l C y r 1 " $ A r i a l C y r 1 " A r i a l C y r 1 " A r i a l C y r 1 h 8 C a m b r i a 1 , 8 C a l i b r i 1 8 C a l i b r i 1 8 C a l i b r i 1 C a l i b r i 1 C a l i b r i 1 C a l i b r i 1 ? C a l i b r i 1 4 C a l i b r i 1 4 C a l i b r i 1 C a l i b r i 1
C a l i b r i 1 C a l i b r i 1 C a l i b r i 1 C a l i b r i 1 C a l i b r i / # , # # 0 " @. " ; \ - # , # # 0 " @. " 9 # , # # 0 " @. " ; [ R e d ] \ - # , # # 0 " @. " ; # , # # 0 . 0 0 " @. " ; \ - # , # # 0 . 0 0 " @. " E # , # # 0 . 0 0 " @. " ; [ R e d ] \ - # , # # 0 . 0 0 " @. " k * 3 _ - * # , # # 0 " @. " _ - ; \ - * # , # # 0 " @. " _ - ; _ - * " - " " @. " _ - ; _ - @ _ - k ) 3 _ - * # , # # 0 _ @_ . _ - ; \ - * # , # # 0 _ @_ . _ - ; _ - * " - " _ @_ . _ - ; _ - @ _ - { , ; _ - * # , # # 0 . 0 0 " @. " _ - ; \ - * # , # # 0 . 0 0 " @. " _ - ; _ - * " - " ? ? " @. " _ - ; _ - @ _ - { + ; _ - * # , # # 0 . 0 0 _ @_ . _ - ; \ - * # , # # 0 . 0 0 _ @_ . _ - ; _ - * " - " ? ? _ @_ . _ - ; _ - @ _ - "$"#,##0_);\("$"#,##0\) ! "$"#,##0_);[Red]\("$"#,##0\) " "$"#,##0.00_);\("$"#,##0.00\) ' " "$"#,##0.00_);[Red]\("$"#,##0.00\) 7 2 _("$"* #,##0_);_("$"* \(#,##0\);_("$"* "-"_);_(@_) . ) _(* #,##0_);_(* \(#,##0\);_(* "-"_);_(@_) ? : _("$"* #,##0.00_);_("$"* \(#,##0.00\);_("$"* "-"??_);_(@_) 6 1 _(* #,##0.00_);_(* \(#,##0.00\);_(* "-"??_);_(@_) #,##0.00;[Red]#,##0.00 " " " " " " " " " " " " ! ! ! ! ! ! ! ! ! ! ! ! , * P P a > ff ` + ) ( # < $ " " 4 " < " 8@ @ * <@ @ * 8@ @ * <@ @ ( , , ( " < $ 1 1 (@ @ ,@ @ ,@ @
1 " <
1 " < 1 " " @ 1 " < " @ < <
< <
1 " 4 ) K2>4 *
KG8A;5=85 + , - . 03>;>2>: 1 / 03>;>2>: 2 0 03>;>2>: 3 1 03>;>2>: 4
2 B>3) 3 >=B@>;L=0O OG59:0 4 0720=85 5 59B@0;L=K9 6 7 ;>E>9 8 >OA=5=85 9
@8<5G0=85 :% ; !2O70==0O OG59:0- ? %>@>H89` f PriceExl = " fV f @ @ Z R # 3 @ @
* a ! ;D028B H:>;L=8: ( 7 - 1 4 ;5B) B01 N 6 0 ;D;CB>? 1 0 <3/ 1 <; N 1 0 0<? Biotehnos S.A.& ;L45F8= 5 0 7 =07. A?@59 8 , 5 3* * Schering-plough 135.50 ;LD5B8= ;8>D ?>@ 0<? 7 5 ;>388 $ <0@8; 2 <3 N 3 0 B01 Aventis <0@8; 4 <3 N 3 0 B01 15=5 1 5 <3/ 5 <; 1 0 0 ? Merckle 15=5 3 0 <3 N 2 0 B01 35:A0; 3 0 <3 N 2 0 B01 Hexal Pharma Gm <8:A8= 1 2 5 <3 N 1 0 B01* 0;LE8<D0@<- 0AB5@;5: <8:A8= 1 2 5 <3 N 6 B01* <8:A8= 6 0 <3 N 1 0 B01* = 0 , 2 5 N 1 0 0 B01 :@8E8= 48! :0?@>=>20O :8A;>B0 5 % 1 0 0 <;* -! ?;07<0;L 5?0 @- @ 1 0 % 5 0 0 <; B.Braun Melsungen AG 3861.40 48?8=- 8>:>< 1 0 :>< <<80:0 @- @ 1 0 % 4 0 :A0@A:0O $$ >4=K5 B5E=>;>388 8 <0@:5B8=3 :A8:;02 3 7 5 <3 N 1 5 B01* * 219.28 :A8:;02 6 2 5 <3 N 1 5 B01* * 326.85 :A8F8;;8= 5 0 0 <3 N 1 6 :0?A
Hemofarm d.d.$ A8= 0 , 2 5 N 1 0 B01 ( :A8F8;;8=) * * 16.00 324 A8= 0 , 5 3 N 1 0 B01* 64 :A 2 5 0 2 . 80" ;L 0 , 5 3 D;* 400/50" <?8F8;;8=0 B@8384@0B 0 , 2 5 N 2 4 B01 29.50 68 =0;L38= 0 , 5 N 1 0 B01* * !$0@<0 2.10 =0;L38= 5 0 % 2 <; N 1 0 0<?* 55 =0;L38= 5 0 % 2 <; N 1 0 0<?* * 28.50( =0;L38= AC??. @5:B. 0 , 1 3 4/ 45B. N 1 0 A 3 ;5B 86D0@< 100( =0;L38= AC??. @5:B. 0 , 2 5 3 4/ 45B. N 1 0 A7 ;5B =0;L38=- %8=8= N 2 0 B01 Sopharma 400/10 =0?@8;8= 0 , 0 1 N 5 0 B01* *
"0BE8<D0@2;5=85 $ 680 =0?@8;8= 0 , 0 4 N 5 0 B01* * 548A>@1 10.40 280 =0D5@>= N 2 0 B01 2 :0@B. C?. ( =0D5@>= 45BA. N 2 0 B01 ( ?/ ?@>AB4, ?/ 3@8??) 240% =0D@0=8; ! 7 5 * Novartis P/Ciba =40=B5 ( 0;5?;>=) 1 0 ; N 1 0 A25G8 =65;8: 2 4K 5 0 3 $8B>- -@@@;8F09 N 2 0;B8@# =B8?>;8F09+ M=5@38O :>D5 N 2 42>9=>9 =B8?>E ;NA =B8AB0:A 1 8 0 <3 :0?A. N 1 0 0 Pharmaton =B8AB0:A 1 8 0 <3 :0?A. N 5 0 =B8AB0:A 35;L 1 2 5 <; 5@8=35@ =35;LE09; N 1 0 AC??. @5:B ?870@B@>= 2 0 3 25;L 1 5 0 18;L=0O $-!" $-!" @020 2 0 * * Aventis/Hoechst 2800.20 @184>; 1 0 0 <3 N 1 0 :0?A
)- 0AB5@;5: 330 )- $0@; 5 0 = 2 , 5 = @5B0@4 1 , 5 * * 281.88
@B@0 N 6 0 B01
UNIPHARM Inc. @B@>D>>= N 4 0 B01 2 :0@B. C?. @B@>F8= N 3 6 B01 & $0@<0- ! @CB8; 3;. :0?;8 0 , 2 5 % 5 <;*
ANKERPHARM @CB8; 3;. :0?;8 0 , 5 % D;. 5 <;* A5=B@0 5 0 * * KRKA 575.26( A5?B0 >?>;0A:. 4/ @B0 1 5 0 @18=>20O :- B0 0 , 0 5 N 2 0 0 4@065* *
0@18>D0@@18=>20O :- B0 2 , 5 3 ?>@- : 600! A:>@18=>20O :- B0 5 % 1 <; N 1 0 02480;5:" A:>@18=>20O :- B0 5 % 2 <; N 1 0 0@18=>20O :- B0 5 0 0 @B8 $0@4C:B( A:>@18=>20O :- B0 5 0 0 <3 N 3 0 B. 1/ A !@>48( A:>@18=>20O :- B0 5 0 0 @18=>20O :- B0 5 0 0 D0@@18=>20O :- B0 5 0 0 @18=>20O :- B0 5 0 0 @B8( A:>@18=>20O :- B0 5 0 0 @18=>20O :- B0 5 0 0 @18=>20O :- B0 5 0 0 @18=>20O :- B0 5 0 0 <3 N 3 0 B01. 652. !@>( A:>@18=>20O :- B0 N 1 0 A:>@18=:0 ( :@CB:0 - 8= A:>@8; A8@>? 2 0 0 @CB8= N 5 0 B01 >7D0@D5=- N 1 0 B01 $0@<AB0=40@B- 5:A@54AB20 C@A: 500 A?0@:0 1 0 0 @. 4/ ?@83. @- @0 N 1 0 ?0: A?8@8= ! N 1 0 H8?. B01 20/120( AB8= 10;L702 7 5 @25B $0@G=8: >;3>;5B B0:0=4 8 <3 N 2 8 B01* * Astra 1114.57 B0@0:A 2 5 ;>; 5 0 ;>; 8:><54 1 0 0 ;>;- @0B8>D0@< 2 5 <3 N 3 0 B01* * Ratiopharm/Merckle 23.33 B@8:0= 2 5 0 <3 N 8 :0?A Innothera "$ 1 % 1 <; N 1 0 0<? C3<5=B8= 3 7 5 <3 N 2 0 B01* * SmithKline Beecham/Glaxo C3<5=B8= 5 0 0 <3/ 1 2 5 <3 N 1 4 B01* * SmithKline Beecham 444.26# C3<5=B8= 8 7 5 <3/ 1 2 5 * * 314.30 C@>18= <07L 2 0 3 D0;0 N 1 0 0 B01 D;C18= 2 0 <; :0?;8 Bittner Richard Gmbx D;C18= 5 0 107>; 1 0 ;L 4 0 0 =. ) F8:;>28@ 0 , 2 N 2 0 B01* !B8- 54- !>@1 7>= 540 F8:;>28@ 5:A0; 5 % 2 3 :@5< 28@ 70 N 1 0 0=0D0@< && 1 0 0 =3 6 0 0 <5B 5 0 0 *
Lab.Bago S.A.$ 03><5B 8 5 0 ?@>;>=3. 459- O* ! 03>?@8;( -=0;0?@8;) 1 0 ?@8;( -=0;0?@8;) 2 0 ?@8;( -=0;0?@8;) 5 ;>B=K9 ?>1538 5 0 3( 04>;0 :@5< =56=K9 7 5 ;0 4/ <;045=. 0;L?89A:. 2 0 0 ;0 ?5=0 4/ =>2>@>6. =56=0O 2 0 0 <; 0 1 1 7 04O30 35;L 5 0 @B5 35;L 7 5 @B5 35;L A ?G5;. O4>< 7 5 = ! 35;L 5 % 4 0 3 Lab.Galderma 0:B8AC1B8; N 2 0 :0?A* !>B5:A/ M a r i o n M e r r e l l 0;L70;>B0O 725740" 4 3 Danang 10/1000( 0;L70;>B0O 725740" :0@0=4. 4/ 8=3 1 , 3 0;L70< 8BB=5@0 2 5 0 <; D;( 0;L70< . 8:C;O <0AA06=K9 7 5 @0- $0@<( 0;L70;. ACAB07 5 <;0 9 8 6 ( 0;L70OA=8F) 7 5 <; 0;L70@B82=K9 7 5 <;( 0;L70AB0=>2. 8 0I8B0 4 , 8 30 6 3 1 NIVEA( 0;L70< 4/ 3C1 ;0AA8: A 6>104 , 8 ( 0;L70F5;C94 , 8 30 8 3 9 ( 0;L704 >7>20O 1 0 <; 1 5 3 9 ( 0;L7070 4 , 8 3 0 6 6 2 ( 0;L70;LH0 0=406 =0 3>;5=L N 1 $0@;5=L N 2 0=406 =0 3>;5=L N 3 ' 0=:8 20:CC;8- AB5:;O==K5 ;L?8=0 ;0AB 0@0;38= 5 <; N 5 0<?* 0@ACG89 68@ 1 0 0 - !8;0# 0@ACG89 68@ A A8;0$ 0@ACG89 <0AA06=K9 10;L70< 5 0 @25B $0@: 4/ 45B59 0 , 3 N 1 0 0 :0?A( 0@E0B=K5 @CG:8 :@5< 4/ @C: 70I8B8 0 <;5 9 8 9 0;8=0( 0@E0B=K5 @CG:8 :@5< 8=B5=A82. 8 0 <; 7 8 4 5 ( 0@E0B=K5 @CG:8 684. C2;06. 2 4 5 <;0 8 5 3 ( 0@E0B=K5 @CG:8 684:>5 7842 4 5 # 0@E0B=K5 @CG:8 ( 2 :@5<0 4/ @C:) ( 0@E0B=K5 @CG:8 ! 8 0 <; 9 0 3 0 0E8;K ?/ MB. AB@>2K5 V i v a N 5 0 Heinz Herens( 57>@=8; =5G=8:8 4 HB) Mayinglong Pharmaceuticals( 5918 0;< ?@8 @87<5 4/ <;045=F. 1 5 = N 6 B01 5;;0AB578= N 1 0 B01 5;;0B0A0;8: ;>AL>= 5 0 A0;8: 3B :>=F- B A 94 5 3 9 Barbra Laboratories# 5=78;?5=8F8;;8=0 N a A>;L 1 E8<8: 3.50 200/50 5?0=B5= 5 % 3 0 3 :@5< Hoffmann-La Roche Nicolas 5?0=B5= 5 % 3 0 3 2K5 ?>G:8 3 5 3 5@>4C0; 1 0 7 0M@* * Boehringer Ing. 329.50 5@>4C0; @- @ 4/ 8=30;. D;. 2 0 B5: 1 0 0 702 0 0 4>7 0M@ 1 0 <;* * Boehringer Ing 173.73 5@CH8 M o l d e x P o c k e t P a k N 4 Moldex 5@CH8 #H=K5 2:;04KH8 N 4 !0;L20<54/ E v r o s i r e l $0@:B 5A0;>; N 6 B01 300 5AA<5@B=8: ?5AG0=K9 F25B:8 3 0 3 5B048= AC?. 203. 2 0 0 : B01. ?@>;>=3. 4- O 1 0 0 <3 N 3 0 * * Astra Zeneka 351.61 5B0A5@: 8 B5:A $0@<D8@<0 5B0A5@: 8 <3 N 3 0 B01* *
Solvay Ph. 267.33 5B0A5@: 1 6 A ?>@ 4/ ACA? 2=. ?@8= N 1 3 3 ?0:. 0@0D0@< 8=B =5AB5@8;. 1 0 < E 1 6 A< 8=4. C? EB0<0@ 8=B =5AB5@8;. 5 < E 5 A< 8=4. C? 8=B =5AB5@8;. 5 < E 7 A< 8=4. C? 8=B =5AB5@8;. 5 < E 1 0 A< 8=4. C? 5@0 54 8=B =5AB5@8;. 7 < E 1 0 A@B 8=B =5AB5@8;. 7 < E 1 4 A< 8=4. C? 400 250( 8=B =5AB5@8;. 5 <E1 0 A< N 1 ( 3@C?. C?0:. 2 5 HB)
-25@A- $0@< 25 8=B AB5@8;. 1 0 < E 1 6 A< 8=B AB5@8;. 5 < E 1 0 A< 8=B AB5@8;. 5 < E 5 A< 8=B AB5@8;. 5 < E 7 A< 8=B AB5@8;. 7 < E 1 4 A<( 8=B B@C1G0BK9 =B5:A N 3 0 . 1 5 <E2 . 5 A@?>@0F8O ( 8=B B@C1G0BK9 =B5:A N 4 0 . 1 5 <E3 . 0 AAB8= :0?A. 0 , 5 3 N 3 0 75( 8>10:B>= 0 . 5 3 D;. 1 0 D. ?>@>H>:) $# 8>28B0;L N 6 0 4@065 50/5 8>28B0;L 35;L 1 7 5 3 4/ 45B59 8>?0@>:A 4 0 0 4>7 2 0 48; 5 $ 8A0:>48;- 86D0@< 1 0 48;- %5D0@< 5 ; 1 2 0 ; 4 8 0 <3 N 2 0 B01* * 8D84C7 N 1 0 D;0:* * -:>?>;8A 46.00 8D84C7 N 1 0 8D84C7 N 2 0 8D84C7 N 3 0 % 8D84C@. 5 4>7 N 1 0 ?0:5B* * 0@B=5@ 62.00 150% 8D84C@. 5 4>7 N 3 0 ?< 0:5B* * 154.40 8D84C70 N 1 0 37.00& 8D84C@B5 5 4>7 N 1 0 ?0:5B* * 85.80& 8D84C@B5 5 4>7 N 3 0 ?0:5B* * 240.62 8D8;87 AC?? N 1 0 $5@9 - 5 4>7 N 1 0 ?>@. D; 8D8D>@;NAK %C0B> 8 0 3 Cisin >@0 >@0 3 5 0 @=0O :- B0 1 0 3 ?0:5B! >@=>9 :8A;>BK @- @ A?8@B. 3 % 1 0 A;02A:0O $$ 81 >@> ?;NA 2 5 3@( 75;5=K9) Himami Limited 12/240 >@> ?;NA 2 5 3@( @>7>2K9) >@>20O O@KH=8: N 2 0 B01( 5;5=K9 >:B>@) >O@KH=8:0 =0AB>9:0 2 5 2A:0O $$ >O@KH=8:0 ?;>4K 1 0 0 3 >O@KH=8:0 ?;>4K 2 , 8 3 N 2 0 D/ ? >O@KH=8:0 F25BK 2 , 0 3 N 2 0 D/ ? 84 @0; 5 0 0 <3 N 2 0 B01 Micro Lads Ltd @8;;. 75;. A?8@B. @- @ 1 % 1 0 <;' @8;;. 75;. A?8@B. @- @ 1 % 1 0 <35:A8= 0 , 0 0 8 N 1 0 B01 $0@@ ?@>40:H= @><35:A8= 0 , 8 <3/ <; 1 5 0 <; <35:A8= 4 <3/ 5 <; 6 0 <; <35:A8= 8 <:0@0 0 , 2 5 N 3 0 B01 130 @>=E>- <C=0; 7 =E>- <C=0; 3 . 5 =E>A0= :0?;8 2 5 3>@A:. 7- 4 !% CA5@5;8=- 45?> 4/ ACA?5=. 3 , 7 5 <3 N 1 D;* $0@= 5 % 2 0 3 <07L KAB@CB8; D;. 3 6 % 5 0 3 Polfa 070?@>AB0= 2 0 <:3 N 1 0 0<? * Schwarz Pharma 075;8= <548F8=A:89 2 5 3
$" $ - - 075;8= 2>5 1 0 0 2>5 2 5 <; D; "25@A:0O $$ 49 078;8? 1 0 * * K R K A - #! 398.29 07>1@0; N 3 0 B01 Chiesi 07>1@0; @- @ 5 0 :5B 6 0 0 <3 N 3 0 B01 09@=. 1 , 5 3 N 2 0 D/ ? 0;5@80=0 :>@=528I0 5 0 3 0;5@80=K =0AB>9:0 2 5 ; 0 , 0 6 N 1 0 B01 0;84>; A 3;N:>7>9 0 , 0 6 N 1 0 B01
"N:>@48= :0?;8 2 0 :>@48= :0?;8 5 0 A5@48= 1 5 A5@48= 2 5 <; 2 8=4. C?. 0=L"C= 2 8 0 <54 2 , 5 <3 N 5 0 B01* * 80.54 0B0 <5;8O 3;07=0O 20B0% 0B0 <5;8O =5AB5@. 783- 703 E8@C@35 0 3@& 0B0 <5;8O =5AB5@. <54. 38385=. 2 5 0 30 0 5 4 0B0 <5;8O =5AB5@. E8@C@3. 1 0 0 3@! 0B0 ?>: 1 0 0 3@ 2 @C;>=5 1 0 4 7 " 5;;0" 3. 3>@L52A:& 0B0 5;;0 E;>?>: 5 0 3 2 @C;>=5 1 0 5 4 0B0 38385=8G5A:0O <548F. 2 5 3 0B0 38385=8G5A:0O <548F. 5 0 3 0B0 38385=8G5A:0O <548F. 1 0 0 3 0B0 38385=8G5A:0O <548F. 2 5 0 3 0B0 E8@C@38G5A:0O <548F. 2 5 3 0B0 E8@C@38G5A:0O <548F. 5 0 3 0B0 E8@C@38G5A:0O <548F. 1 0 0 3 0B0 E8@C@38G5A:0O <548F. 2 5 0 3" 0B0 E8@C@38G5A:0O AB5@8;L=0O 2 5 3" 0B0 E8@C@38G5A:0O AB5@8;L=0O 5 0 3" 0B0 E8@C@38G5A:0O AB5@8;L=0O 1 0 0 3" 0B0 E8@C@38G5A:0O AB5@8;L=0O 2 5 0 3( 0B=K5 48A:8 B E L L A N 1 2 0 c B8A=5=85G. N 1 6 0 0B=K5 48A:8 B E L L A N 2 5 56( 0B=K5 48A:8 B E L L A N 5 0 :204@0B=K5 0 7 7 4 ( 0B=K5 ?0;>G:8 B E L L A N 1 5 0 0 9 7 2 0B=K5 H0@8:8 <5;8O N 5 0 0B=K5 H0@8:8 B E L L A N 1 0 0 0 5 6 9 5=8B0= 5 % 5 0 3 :@57>; N 3 6 B01 5=>7>; N 6 0 B01( 5=>7>; 35;L ?@8 20@8:>75 5 0 ;8= 1 0 0 7 0M@* Glaxo Wellcome 5@0?0AC4K 5 0 <; :0?;8 LN@0- D0@< 5@:A 1 0 0 H?8@>= 2 5 <3 N 2 0 B01* * 34.60 180/10& 5@A0B8A B@0=A45@<. B5@0?52B. A8AB5< 5 HB
GRUNENTHAL 5AA5; CM $ :0?A. 2 5 0 N 5 0 * A l p h a W a s s / $0@@( 5AA5; CM $ @- @ 4/ 8=. 6 0 0 2 <; 0<?. N 1 0 * 803@0 1 0 0 <3 N 1 B01 Pfizer 803@0 1 0 0 <3 N 4 B01 PFIZER 803@0 2 5 <3 N 1 B01 803@0 5 0 81@>F8; :0?;8 2 =>A 1 5 ; AC??. @5:B. N 1 2 Biologishe Heil. 848A8: 35;L 3;07=>9 1 0 3 BC10
Bausch & Lomb 878= 3;. :0?;8 1 5 = :0?;8 5 0 ; 0 . 0 1 5 N 2 0 B01 8;L?@0D5= 5 0 0 <3 N 1 0 B01* Yamanouchi/Heinrich( 8=8;8= 5 0 3( 10;L70AB0:>2A:>3>) =0@C6. $0@D0@B@>?8; N 5 0 :0?A 0=>=D0@40:H5= 8=?>F5B8= 0 , 0 0 5 N 2 0 B01* ;A8- $0@F5B8= 0 , 0 0 5 N 5 0 B01* 8?@>A0; 5 0 3 4C@>; 1 0 <; 3;07. :0?;8 D;0: Lab.H.Faure/Ciba Vision$ 8B0<8= - 3 3 0 0 0 0 , 1 5 3 N 1 0 :0?A* 2000/200 8B0<8= - 1 5 % 1 <; N 1 0 0<? 14.00 8B0<8= - 1 2 2 0 0 <:3 1 <; N 1 0 0<< ?* 11.00 13 8B0<8= - 1 2 5 0 0 <:3 1 <; N 1 0 0<?* 8B0<8= - 1 2 5 0 0 <:3 1 <; N 1 0 0D0@< 14.50 104 8B0<8= - 6 5 % 1 <; N 1 0 0<?
@520=A:0O $$ 8B0<8= 4 0 0 <3 N 3 0 :0?A* % 8B0<8= 5 0 % @- @ <0A; N 1 0 :0?A 0 . 2 3* # 8B0;L=KE 48015B>= 10;L70< 5 0 = 10;L70< M18 3 0 = 10;L70< 4;O 45A5= 3 0 = 10;L70<- ;N:A 2 5 AB 5 0 AB B1. 1 0 0 <3 N 2 0 8B@C< N 1 0 0 B01* 8B@C@B5 N 1 0 0 B01* 8B@C< !C?5@AB@5AA N 6 0 B01* 8B@C= = 160.00 8D5@>=- 1 A25G8 1 5 0 BKA. N 1 0 215.00 8D5@>=- 2 A25G8 5 0 0 BKA. N 1 0 300.00 8D5@>=- 3 A25G8 1 1M=78 Mucos Pharma >1M=78 >1M=78 >40 4;O 8=J5:F89 2 <; N 1 0 040 4;O 8=J5:F89 5 <; N 1 0 040 40 40 =0BM g 1 , 0 ; 307 -"1 1 5 7 >;8=A:0 ( >40 4 8=2>4K?8I5?@>4C:B( >40 40 4. AA5=BC:8( >40 40 4 4" 8=2>4K?8I5?@>4C:% >40 40 40 3@04A:85 8AB>G=8:8( >40 40 2>4A:/ 0@70=( >40 40 40 2A:0O 0 , 5 ; 0 4 0 4 ( >40 2A:0O 1 , 5 3070 0 1 4 -;8B0- 8=5@0; & >40 <8=5@0;L=0O "515@40 1 , 2 5 ; 307 -" 0A( >40 @B (8H:8= ;5A %>;48=3( >40 ;>4CH:0 7>;>B8AB0O 5 0 3@( ?5G5=L, 6- :8H) " &!" 3. 0@=0C; >;LB0@5= 1 0 0 ;LB0@5= 5 0 ;LB0@5= M;LB0@5= M:>@?" C:0- C:0 N 6 0 B01 01@83;>18= 2 . 5 3+ @@- B. 5 0 2A:0O AB. - 8O ?5@5;82. :@>2! 0;028B ?>@. 4\ 8= 1 0 0 <3 1 0 @ 0;07>;8= 0 , 0 5 % 1 0 ;8= 0 , 1 % 1 0 <; D;0: 0;AB5=0 2 0 <; :0?;8 D; 0;AB5=0 5 0 <; :0?;8 D;" 0<0<5;8A 3 0 3 ?. 8=4. C?) 36 0@F8=8O- D>@B5 N 4 0 :0?A 4> 0 3 . 0 8 0AB0; N 3 0 B01 Pliva 126 0AB0; N 6 0 B01 54 0AB@>D0@< N 6 B01 Biovet 545;8:A 1 0 0 ? >B :0H;O Meuselbach Pharma 545;8:A 5 0 B :0H;O 5:A8:>= AC??. 203. 1 6 = AC??. 203. 1 6 @0; 0 , 1 % @- @ 2 0 0 @0; 0 , 2 % 4 0 <; A?@59 D;' 5;L 4/ 8=B89 383. C a r e f r e e 0;>M 2 0 0 3 457>4>@0=B -;L<0 5 0 =8@. MD- B0 3 0 3 0 7 3 6
8>:>= ! % 5;L ! /- O F F A B>=8@. MD- >< 3 0 3 0 6 2 0 ( 5;L- <0A:0 E x p r e s s L i f t i n g O=B0@. :- B05 <; 5;5=0O 4C1@020( 5;L- A=A>=) C2;06=8B5;L4 2 3@( 5;L- A71C6. 5 0 <; 0 7 5 2 Condomi( 5;L- A<07:0 V i z i t :;C1=8G=0O 5 0 <; 0 7 3 8 ( 5;L- A<07:0 V i z i t C2;06. 5 0 <; 0 7 1 4 ( 5;L- A<07:0 N@5:A ;59 "8=3; 5 0 <; 8 6 0 0 ( 5;L- A<07:0 N@5:A ;59 %8B 5 0 <; 2 9 6 3 ' 5;L- A=B5:A ?@>4;. L o n g 1 0 0 <;4 0 4 4 C;:0=( 5;L- A 2>71C640NI0O 5 0 <; 9 6 9 0 CRP Productions( 5;L- A C2;06=ONI0O 5 0 <; 9 5 7 7 5;L? 0 , 6 3 N 2 0 B01( 535= 5 0 3 A 28B. ! 0 0 4 0 >7@>645=85 8 @0728B85( 535= 5BA:89 N:A 5 0 3 0 1 8 7 ( 535= N18<K9 -:AB@0 5 0 3 0 1 9 4 ( 535= >2K9 5 0 3@ A ;5A. >@5E>< 0 0 6 4 ( 535= >2K9 N:A 5 0 3@ 0 2 6 2 >7@>645=85 8 @0728B85 ( 535= CAA:89 " !" 4 0 3@ 0 6 6 4 $0@ ( 535= CAA:89 5BA:89 4 0 3 0 6 5 7 ( 535= CAA:89 A :54@. >@5E H>:. 3; 4 0 3( 535= CAA:89 A :54@. >@5E>< 4 0 3 0 6 9 5 288( 535= CAA:89 BC@1> 4 0 3 0 5 1 0 ( 535= CAA:89 BC@1> 7N< 4 0 3 0 6 4 0 ( 535= CAA:89 BC@1> 54>2K9 4 0 3 0 6 0 2 ( 535= CAA:89 BC@1> @5E>2K9 4 0 30 5 6 5 ( 535= ! N:A 5 0 3@ 0 2 4 8 5457- 2 0 0 <; 5457- 4 0 0 <;$ 5=B0<8F8=0 AC;LD0B 4 % 2 , 0 N 1 0 0A 2 0 A 5 0 = 1 0 0 0 0 0 0 N 1 0 AC??
8>:04 5=D5@>= 2 5 0 0 0 0 N 1 0 AC?? 5=D5@>= 5 0 0 0 0 0 N 1 0 AC??:>;LDAB@8< 5?0@8= 5 0 0 0 54/ 1 <; 5 <; N 5 D;* * 5;20O = ;8>D. ?>@. D; 0 , 0 0 2 3 N 1 + @- ;L + H?@8F
<<0D0@<0 5?B@0; 4 0 0 <3 B01. N 2 0 * Knoll/Abbot 5@8<0:A -=5@468 N 1 0 B01 5@8 80D5@>= 5 0 0 0 0 0 N 1 0 AC??
8B0D0@<0 ( 83. B0=K >B5:A <8=8 N 8 5 7 7 9 Kimberly-Clark 16( 83. B0=K >B5:A AC?5@ N 3 2 3 2 1 7 ( 83. B0=K 0BC@5;;0 AC?5@ N 1 6 3 4 0 7 P&G( 83. B0=K 0BC@5;;0 AC?5@ N 8 3 3 7 7 ( 83. B0=K . . =>@<0; N 3 2 4 7 0 3 J&J( 83. B0=K . . @>>@B ;09B N 1 6 1 5 3 2 ( 83. B0=K . . @>>@B =>@< N 1 6 4 2 8 2 ( 83. B0=K . . AC?5@ ?;NA N 1 6 1 4 1 0 ( 83. B0=K " % ><?0: S u p e r N 8 9 6 5 1 ( 83. B0=K " % ><?0: @53C; N 8 9 4 4 6 Procter&Gamble' 83. B0=K " % ><?0: AC?5@ ?;NAN 1 6 ' 83. B0=K " % ><?0:$@5H @53C; N 1 6 ( 83. B0=K " % >@B3 21 N 1 6 @534 5 3 7 ( 83. B0=K " % >@B3 21 N 1 6 AC?4 6 0 5 % 83. B0=K " % >@B3 21 ;09BN 1 6 ( 83. B0=K " % AC?5@ N 1 6 A 0?. 5 0 9 7 18( 83. B0=K " % AC?5@ ?;NA N 1 6 5 1 1 0 84@50 5 0 0 :>@B87>= 0 , 5 % 3;. :>@B87>= 4/ 8= 1 2 5 <3/ 5 <; N 1 D;\ 0:>@B87>=>20O @>AB@. 7- 4 84@>?5@8B 1 , 5 N 8 B01. 8=8?@0; 0 , 5 8;>10 N 4 0 B01( - ) 8=:>@ 35;L 4 0 3 Beaufour Ipsen! 8=>- ?520@8; 1 5 0 :A87>= B80784 1 0 0 <3 N 2 0 B01 * Chinoin 63.07" 8AB0= 0 , 2 3 N 3 6 :0?A ( ?@ 0;;5@388) ( 8AB0= :@5< 3 0 E@>< 0 , 0 2 % 1 <; N 1 0 0>:50=A:89 8=AB8BCB 18>>@30 ;5<07 4 <3 N 3 0 B01 ;80B8;8= 1 0 0 0 <3 4 <; N 3 0<?* I t a l f a r m a c o / $0@@ ;80B8;8= 4 0 0 <3 N 1 4 :0?A* 48C< ;NA 2 <3/ 1 2 5 <3 N 1 2 B01* 48C< ?;NA 2 <3/ 1 2 5 <3 N 4 B01* <?070 N 2 0 B01. 1;. 2 :0@B. C?$ = N 4 0 B01. 4/ @0AA0AK2. 1/ A0E0@0* * D0= 0 , 0 0 5 % 4/ 8 1 <; N 5 0=>:A D0= 1 0 0 <:3 N 5 A25G8
=30;8?B 3 0 <;
;B0928B0= 1 0 0 BKA. N 1 ;8>D. 4\ 8=B@0=07. A @- $0@= =30@>= 5 0 0 BKc N 5 D;* * 4700.00 =30@>= 5 0 0 BKA D;* * ( >B 5 C?) 9400.00 =40?0<84 2 , 5 ; N 1 2 0 :0?A 8@0:A/ 8>$0@; N 3 0 :0?A 8> 54=25AB =4>2078= 35;L 4 5 3 195' =4>:>;;8@ 0 . 1 % 3;07. :0?;8 5 <5B0F8= 1 0 % 4 0 3 <5B0F8= 2 5 600/10& =4><5B0F8= 2 5 ( 8=4. C?. ) 350 =AB5=>= N 3 0 B01 ?/ > 123.41 =AB8;;035;L H?@8F 1 1 = 1 0 0 0 N 1 0 0<54 82 =C28B ?0: 1 8 3 N 1 0 SymbioPharm GmbH =DC:>; - @- @ 6 % 5 0 0 <;* Serum-Werk Bemburg @8D@8= 3;. :0?;8 2 . 5 % 5 7 2 0 <; D;* @C=8= 1 0 0 4- :B82 1 0 0 0 , 2 5 3 N 6 0 B01 - 4 8>4 >4- :B82 N 4 0 B01 >4- :B82 N 8 0 B01 >40 @- @ A?8@B. 5 % 1 0 <; ( 28=B :@)
!0<0@048=>; 1 0 0 4><0@8= 1 0 0 4><0@8= 2 0 0 4><0@8= 2 0 0 :A 0M@. - A?@59 4/ >@>H5=. 3 0 E8<18=- (?835;L 5 = 0 , 5 % 1 0 <3 2 <; N 1 0 0= 5 M A>: 2 0 ?. 22 0;5=4C;K =0AB>9:0 4 0 ;01 0;8O >@>B0B 0 , 5 N 1 0 B01 0;?>; ACA?. 4/ 45B59 1 0 0 <;* * 0;LF5 SAGMEL 0;LF84 0 . 4 3 N 1 0 0 B01 >@B ><?;5:A 0;LF89 3 5 0 0 <3 N 1 0 0 6520B. B01* Nycomed Pharma 0;LF89 3 5 0 0 <3 N 2 0 6520B. B01* 0;LF89 3 5 0 0 3 , 9 N 1 0 H8?. 3@0=. 4/ @- @0
!548:> . " 0;LF8O 3;8F5@>D>AD0B 0 , 2 3 N 2 0 B01
C30=A:89 %$ 0;LF8O 3;N:>=0B 0 , 5 N 1 0 B01 0;LF8O 3;N:>=0B 1 0 % 5 <; N 1 0 0@84 1 0 % 1 0 <; N 1 0 0@84 1 0 % 5 <; N 1 0 0<? 0= 0M@. 3 0 , 0 D;0: 0= 0M@. 3 0 <; 0@=>5 1 0 % 3 0 <; 0@=>5 5 0 <; 0@=K9 A?8@B 1 0 % 4 0 <; 0@=K9 A?8@B 1 0 % 4 0 B8: :0?;8 CH=K5 5 @><) 0=484 2 % 35;L 2038=. 3 0 3 0=484 :@5= N 6 0 4@065 Bionorica GmbX 0=5D@>= :0?;8 D;. 1 0 0 3 3 0 3 0 4 1 6 0?;8 4\ :>=B. ;8=7 R e N u M + 8 <; 0?;8 5;5=8=0 2 5 2A:0O DD 0?;8 7C1=K5 1 0 <; D;/ 784 5 0 / 2 5 B5= 0 , 0 2 5 3 N 2 8 B01 * 116.50 0?>B5= 0 , 0 2 5 3 N 4 0 B01* 157.50 0?>B5= 0 , 0 2 5 3 N 5 6 B01 * 207.00 0?A8:0< ?@8; 2 5 <3 N 2 0 B01* 0@10<075?8= 2 0 0 <3 N 5 0 B01* 102.00 0@48:5B @5B0@4 2 0 <3 N 2 0 B01* * 45.24 0@48:5B @5B0@4 2 0 <3 N 5 0 B01* * 94.64 0@48:5B @5B0@4 4 0 <3 N 2 0 B01* * 76.33 0@48:5B @5B0@4 4 0 3@. 1 0 3 ?0:5B\ :>@>1:0 0@48><03=8; 7 5 <3 N 1 0 0 B01 N Cc o m e d / D a n m a r k A p S 0@4C@0 4 <3 N 3 0 B01* ! 0@;8A ;545=. >B :0H;O 7 5 3 ( A8=) (<8430;;' 0@;8A ;545=. >B :0H;O 7 5 3 1/ A0E ( 75;) ' 0@=8B8=+ %@>< 3 5 0 9=>ABL) N a t u r v i t a a . s . / !2 8 ?0@B= 108 0@A8; 3 5 @>2>5 3 0 ;>= 1 0 0 B5:A 20<0B5; 2 0 <3 N 2 8 B01* * 112.44 20<0B5; 4 0 <3 N 1 4 B01* * 28=0:A 0 . 0 1 5 % 1 5 3 4 0 <3/ 1 <; ACA?. 4/ 8= N 5 0<?* * 333.39 5@0B0= ?@8AK?:0 5 % 5 3 5AB8= 1 0 <3 N 1 0 B01 5AB8= 2 0 Almirall Prodespharma 5B0=>2 1 0 2 3 0 <3/ 1 <; N 1 0 0=0; 1 0 0 <3 2 <; N 1 0 0=0; 1 0 0 =0; 5 % 5 0 <3/ 1 3 :@5=0; 5 0 =0; D>@B5 B01. 1 0 0 @>; 1 0 s lab." 5B>@>; 3 0 <3/ 1 <; @- @ 4/ 8= N 1 0 0B8D5= 0 , 0 0 1 N 3 0 B01 8?D5@>= N 1 0 AC??>78B>@88
;D0@< ;0<8= 0 , 6 5 N 2 0 B01 530 $0@;>=- 0C:0 ;0<8= 0 , 6 5 N 4 0 B01 ;0<8= 0 , 6 5 N 8 0 B01 ;0@8B8= 1 0 <3 N 1 0 B01* * 135.31 ;0@8B8= 1 0 <3 N 7 B01* * 104.04& ;0F84 ! 5 0 0 ;>=3. 459- O* * Abbott lab. 542.05 ;59 <54. $- 6 1 5 3@ BC10' ;5:A0= @- @ 4/ 8=. 2 H?@. 4 0 <3/ 0 , 4 ; 0 , 1 % 1 0 0 ? ;8= 2 0 <3 N 6 0 B01 ;8= 5 0 <; :0?;8 D;- :0? ;8<0:A0= N 2 0 B01 2 :0@B. C? ;8@>1:0 ;8<0:B- E5;L N 5 0 B01 ;8?;0= N 1 0 0 B01 D.H.U. ;8>=- 1 0 0 = CA/ G e d e o n R ;>AB8;1538B 5 0 B@8; 0 , 1 N 6 203. B01* Magistra ;>B@8; 1 % 2 0 3 :@5< Hyperion 252 ;N:20( ACH5=0O, 87<5;LG5==0O) 5 0 3 !B8- @5=8B5: 2 0 <3/ 1 2 , 5 38BC< @- @ 4/ ?8BLO 1 0 <; N 3 0 045;0: N 1 0 2 :0@B. C? B01 >700@ 5 0 :0@1>:A8;070 3/ E; 5 0 <3 N 5 0<?+ @0AB- ;L $0@;4@5:A " @>=E>" 1 0 0 ? 72/12 >;4@5:A " 09B" 1 6 0 ;4@5:A 0:A@8? N 5 ?>@. ;8= >;4@5:A A 28B. ! N 1 2 B01 >;4@5:A %>B@5< ;8= N 1 0 ?>@ >;4@5:A %>B@5< ;8= N 5 ?>@! >;4@5:A %>B@5< ;8=+ @ 96/6! >;4@5:A %>B@5< G/ A@>4. N 1 0 ?>@ >;4@5:A %>B@5< G/ A@>4. N 5 ?>@( >;;035= #;LB@0 :@5< 8 0 3/ 7 5 <; 0 8 2 0 8B0;- $0@=:>@ ( 8A>?@>;>;) 1 0 =:>@ ( 8A>?@>;>;) 1 0 =:>@ >@ 2 , 5 =B59=5@ 4/ :>=B ;8=7 A l l e r g a n A;0=48O >=B59=5@ 4/ :>=B. ;8=7 R e N u E y e s >=B@0F5?B8= " AC??. 203. N 1 0 >@20;>; 2 5 @20;>; 5 0 @40D;5:A 2 0 ;>=3. 459- O* 78.43 >@480<8= 2 5 % 2 <; N 1 0 0@530 :@5B57>2 D8:A0F884 0 3 >@870;8O B01. ?/ > N 4 0 Boiron >@8;8? AC??. @5:B. 5 0 <3 N 1 0 ;LBD0@@8=D0@ 1 0 * * AWD 96.23 10/240 >@=5@535;L 3;. 35;L 5 % 1 0 3 Dr.Gerhard Mann >@=5@535;L 3;. 35;L 5 % 5 3# >@B5:A8= ;8>D. ?>@. 4/ 8=. 1 0 D0@ABK;8 4/ 27@. 0;NABK;8 4/ 27@. ABK;L 4/ 27@. ;>:B. A @53. 2KA>B2 4 >D58=- 15=7. =0B@8O 0 , 1 N 6 B01 >D8F8;- ?;NA N 1 0 B01 0@=0C;LA:89 7- 4 @0?820 ;8AB 1 , 5 3 N 2 0 D/ ? @0?820 ;8AB 5 0 3! @0A02:8 M:AB@0:B 0 , 0 1 5 N 1 0 AC??. 255 @0A=K9 :>@5=L 0 , 5 3 N 6 0 B01' @5< C a r e l a n 3 0 <; 4/ 3@C48 15@5@A?@>D- ' @53 5 - 4=59 ( ?0AB0) ?@>B82>7. 1 0 3 !0=:B- 5B5@1C@3A:0O $$( @53 5 - 4=59 >1;5?8E0 70682. 3 0 32 5 6 9 ( @53 5 - 4=59 >B 70?0E. ?>B0 3 0 3@0 2 4 4 ( @53 5 - 4=59 >B B@5I8= 3 0 3 5 2 2 5 ' @53 5 - 4=59 A < G09= 45@. 3 0 3( @53 5 - 4=59 C2;. 28=>3@04 3 0 3 2 5 8 3 & @53 -;L<0 A B5;01 0 0 <;( @53 -DD5:B A ?8EB. 1>40 77( @5< 5BA:0O 0?B5:0 4/ @C: 45B59 5 0 <;0 8 9 7 ( @5125B@82. ;8F0 8 8 0 & @53@52. A 10@A. 0 8 6 6 ( @51>40 2 3 0 4 @5< 45BA:89 4 0 3@. ;8A0 1 6 2 8 ( @5< 45BA:89 4 1 3@ "8:- "0: 1 6 0 4 ( @5< <0AA06=K9 0;5B 4 0 3 8=4. C? 0 7 8 2 ( @5< ?/ 1@= 1 0 0 0 0 1 5 0 2>E;51:0 :>@=528I5 8 :>@5=L 1 0 0 3 @CH8=K :>@0 2 , 0 3 N 2 0 D/ ? -=A8 @CH8=K M:AB@0:B 0 , 2 N 1 0 B01 ?/ > A0;0B0= 3;. :0?;8 0 , 0 0 5 % 2 , 5 ;0 =8:>B8=0B 1 5 % 2 <; N 1 0 0<? A5=8:0; 1 2 0 <3 N 2 1 :0?A 216 A5=8:0; 1 2 0 <3 N 4 2 :0?A A5=8:0; 1 2 0 :0< 8 N y c o m e d - !>B5:A A870; 5 UCB A8;5= 0 , 1 % 1 0 <; :0?;8 :@KH/ :0? - !- D0@< 264 A8<5;8= 0 , 0 5 % 1 0 <; :0?;8 A8<5;8= 0 , 0 5 % 1 5 <; A?@59 C45A0= D;- :0?5;L=8F0 2 0 ;18:8 A @K;LF0<8 3 0 3 C@0=B8; 2 5 <3 N 1 0 0 4@065
Berlin-Chemie C@0=B8; N 2 5 <3 N 1 2 0 B01 C@8;LA:89 G09 3 0 3( ;0?G0B:0) 078:A 1 % 2 <; N 1 0 0<?* * 48.17 078:A 4 0 ;20= 1 5 <3/ 5 <; 1 0 0 ? 07>;20= 3 0 ;20= 3 0 <3/ 5 <; 1 0 0 ?( 0: #<=0O -A=>2+ C:@5?+ ?>:@KB1 5 Frenchi( 0: #<=0O -A=>2 1 5 <;1 2 1 2 ( 0: #<=0O -:@KB1 5 <;1 2 1 3 ' 0: #<=0O -AAB0=>28B5;L 1 5 <;1 2 0 4 ( 0: #<=0O M<0;L 35;L C:@5?. C2;. 1 5 <; 1 2 1 6 ( 0: #<=0O -<0;L 35;L C:@5?8B5;L + ! 1 2 0 0 ( 0: #<=0O M<0;L !0;D5B:8 4/ A=OB. ;0:0 N 1 0 ( 0: #<=0O -<0;L AC?5@70I. 28B. 81 5 <;1 2 0 2 ( 0: #<=0O -<0;L C;LB@0 1;5A: 28B. , 1 5 <;( 0: #<=0O -<0;L CA8;8B5;L F25B0 1 5 <;1 2 0 9 ' 0:0;NB 5=B :@5B57. 4 0 3 <OB0
@:0< <1%( 0:0;NB 5=B0; 7C1. =8BL 2 0 < 3 1 0 7 ' 0:0;NB 7/ 35;L T e e n s 8 + 5 0 <; 6 6 8 5 ( 0:0;NB 7/ ? B r i l l i a n t W h i t e C l a s s i c 5 0 <;& 0:0;NB 7/ ? B r i l l i a n t W h i t e M e n t a 5 0 <;( 0:0;NB 7/ ? B r i l l i a n t W h i t e S e n s i t i v 5 0 4 ;5B 5 0 <; 6 6 6 1 ( 0:0;NB 7/ ?0AB0 :B82 5 0 <; 1 3 4 9 ( 0:0;NB 7/ ?0AB0 !5=A8B82 5 0 <; 1 3 7 0 ( 0:0;NB 7/ ?0AB0 #09B 5 0 D>@<C;0 5 0 @ 5 0 <; 1 3 6 3 ( 0:0;NB 7/ I5B:0 Z 3 ( 3 2 1 ) 1 2 4 0 ( 0:0;NB 7/ I5B:0 :B82 6 7 2 2 ( 0:0;NB 7/ I5B:0 54 45BA:0O ?>;0A:820B5;L =B8?;0: 2 5 0 ?>;0A:820B5;L $@5H 7 5 ;>AB8 @B0 2 0 <; 0 6 9 4 # 0:A830; 7 5 <3 @- @ :0?;8 1 0 <; D;/ :0? Galena( 0:B0F84 $5ABL 4/ 8=B. 383 2 5 0 D8;LB@C? 3 0 0 3 $5;8F8B0- E>;48=3 0<878; 1 % 1 5 3 :@5<* 0<878; 1 % 3 0 3 :@5<* 0<878; 2 5 0 <3 N 1 4 B01* * 1692.83 0<878; 5@<35;L 35;L 1 % 1 5 3 0<878; A?@59 1 % 1 5 <; D;0: 0<878; A?@59 1 % 3 0 =B N 2 0 B01 Heinrich Mack nachf. 0F8?8; 4 B>=8O, E@. 0;:>3. 528B@0 1 0 <3 N 4 B01 528B@0 2 0 <3 N 1 B01 528B@0 2 0 ;L <8F5B8=0 A?8@B. @- @ 3 % 2 5 A8= <07L 4 0 3 ( BC10) ' 545=FK S u l a 1/ A0E. 4/ 4801. @59?D@CB 6 0 3 !C;0- 25@: !C25;( 545=FK S u l a 1/ A0E. 4/ 4801. 5A=0O O3. 3 5 3@( 545=FK S u l a 1/ A0E. 4/ 4801. 8= 5;8A03 5 ( 545=FK S u l a 1/ A0E. 4/ 4801. C;LB826 0 38 0 4 7 & 545=FK S u l a 1/ A0E. 4/ 4801. 1;5?8E0 6 0 3' 545=FK S u l a 1/ A0E. 4/ 4801. '5@=. A@. 6 0 3& 545=FK ! >B :0H;O 5A=0O O3>40 3 5 3 Riclan S.A.' 545=FK ! >B :0H;O 0;8=>2K9 G09 3 5 3# 545=FK ! >B :0H;O 54- ;8= 3 5 3' 545=FK ! >B :0H;O OB0- -2:0;8?B 3 5 3' 545=FK - @"09AA =8A- $5=E5;L+ 28B. ! 5 0 3
Naturwaren! 545=FK - @"09AA C78=0+ 28B. ! 5 0 3 545=FK >48@>20==K5 3 0 3
C;:0=& 548A D- ;0 4/ 4" 8B0 8H:8" 652. ?0AB. N 6 0 PHARMA-MED Inc( 548A D- ;0 4/ 4" < 8H:8" 652. ?0AB. N 6 0 $ 548A D- ;0 4/ 4" 0;LF89 8H:8" N 6 0 ?0AB' 548A D- ;0 4/ 4" >;828B0;LH5, G5;828B" N 6 0 ( 548A $- ;0 4/ 6" / :>68, 2>;>A, =>3B" CA8;N 9 0 & 548A D- ;0 4/ 6" / :>68, 2>;>A, =>3B59" N 6 0 ( 548A D- ;0 4/ 6" / G5?>;>2>9 A8AB5?0C70 45=LN 3 0 + =>GLN 3 0 ! 548A D- ;0 4/ 6" 5=>?0C70" B01. N 9 0 ( 548A D- ;0 4/ 6" G8I5=85 >B H;0:>2, " 6 0 + 6 0 ' 548A D- ;0 4/ 6" 5@A>=0;. <5AOG=. A- AB. B:0=8" N 6 0 % 548A D- ;0 4/ ;LH5, G5;828B" N 6 0 # 548A D- ;0 4/ B5=F80; $>@B5" N 3 0 ' 548A D- ;0 4/ AB0B0 $>@B5" N 6 0 :0?A$ 548A D- ;0 4/ <" !?5@@. 5 3 N 3 0 548A D- ;0" V I P " N 1 2 0 B01 5::5@ 3 4) 5::5@ 5::5@ !: 3 <; ( A0;8F8;. :- B0) 5::5@ $: 3 @F8=) 5::5@- =B8?83<5=B 3 @0B>@8O :>A2>3> 75;5=>3> 1 % @- @# 5::5@- >4 @0AB2>@ A?8@B>2>9 5 % 3 <; 5A?5D;0= 1 0 0 20==K9 1 7 0 3@ R i c e l a n d F o o d s - 0A;> 8 ;< 5F8B8= 5F8B8= 0H 0 , 4 5 N 9 0 :0?A .28:A- $0@; AC??. 203. 4 0 0 <3 N 5 84070 6 4 1 <; N 1 0 0:08= 3/ E 1 0 % 2 <; N 1 0 0:08= 3/ E 2 % 2 <; N 1 0 0:08= A?@59 1 0 % 3 8 3 878B 4 1 0 ;;C:A 878B :@5< 3 0 10:B B01. 4/ @0AA0AK20=8O N 3 0 Bosnalijek d.d. 8:>?84 1 0 ?84 1 ?@>D8B 5 0 0 AB0B. 045=>< 87>B 3 0 <; :0?;8 8=40:A0 :0?A. 1 0 <3 N 3 0 8=40:A0 :0?A. 1 5 N 2 1 8=5:A N 1 6 :0?A 8=5:A N 3 2 :0?A. D;0:>=( 8=8<5=B 10;L70 8H=52A:><C 3 0 3 BC10 $0@20F8O 8=8= <07L 3 0 3@ BC10 8=:0A 9 0 ? >B :0H;O Herbion 8=:><8F8=0 3/ E 3 0 % 1 <; N 1 0 0B>= 1 0 0 0 5 0 3 35;L( 8?>DC=48= !"/ !" M<C;A. 4/ 8=D. 1 0 % 5 0 0 35AB N 2 1 4@065 >:>84 0 , 1 % 3 0 3 <8;0= 1 0 ?548C< 2 ?548C< 2 ?5@0<84 2 ?5@0?5@0?CE0 :>@=8 5 0 3 20= '09 105 >@035:A0; 1 0 @8=45= 1 5 3 A5: ! 1 0 AL>= :B82=K9 >B C3@59, ?@KI59 1 0 AL>= >G8I0NI. >@=K9 G8AB>B5; 1 5 0 4=0O 01>@0B>@8O / >AL>= A0;8F8;. :>A<5B8G. 1 0 0 <; %8<A8=B57- $0@B>@3 >AL>= A0;8F8;. >3C@5G=K9 1 0 0 AL>= A0;8F8;. A :0;5=4C;>9 1 0 0 AL>= A0;8F8;. A :@0?82>9 1 0 0 AL>= !0;8F8;. A ;5?. @>7K 1 0 0 AL>= A0;8F8;. A >1;5?8E>9 1 0 0 AL>= A0;8F8;. A @>9 1 0 0 ;O @- @ 2 3;8F5@8=5 2 5 AB>2A:0O $$' N:@8= 5?> 3 , 7 5 <3+ @- ;L 2 :A N 2 0 B01* 00;>:A ACA?. 2 5 0 :A ACA?. ?0:. 1 5 <; N 3 0 * 03=5 6 N 1 0 0 N 5 0 03=8O AC;LD0B 1 0 3 ?0:5B. 800 03=8O AC;LD0B 2 5 % 5 <; N 1 0 0?0@ 2 0
elmos
icq
thuraya sg 2510
dimplex model magic (sp8)
soflens comfort
5440.11 ()
3d
de luxe 5040.11
1000
salamander
646
2114
hi-fi
hp
raymond weil
zanussi
raymond weil
775
.
32
sony ericsson k790i
knauf
man
ipsec
ardo
-
k610
intex
-4361
dhl
-
fifa 2006
funke
754
5004.13 ()
2114
rlc
asko
sky link
ariston
478
-134 .-
-
nokia 8910
motorola v3i
hp
electrolux
r-600
isdn
hotbird
kiev apartaments rent
ielts
.